THORNROSE VENTURES
Lobbying for MEDSIGN INTERNATIONAL CORPORATION · MedSign International Corporation operates as a specialized healthcare technology.
Engaging the Federal Aviation Administration (FAA) and the Department of Transportation (DOT) to support a 24-month Research, Development, Test & Evaluation (RDT&E) partnership aimed at reducing preventable in-flight medical diversions on commercial airlines. Advocating for future FAA rule making and operational standards regarding in-flight medical collaboration capabilities. Promoting the adoption of AI-powered governance platforms (specifically the Qortex AI Master Agent and Worker Agents) to automate clinical workflows, identity verification, and medical documentation in highly regulated transportation settings.
Engaging the Federal Aviation Administration (FAA) and the Department of Transportation (DOT) to support a 24-month Research, Development, Test & Evaluation (RDT&E) partnership aimed at reducing preventable in-flight medical diversions on commercial airlines. Advocating for future FAA rule making and operational standards regarding in-flight medical collaboration capabilities. Promoting the adoption of AI-powered governance platforms (specifically the Qortex AI Master Agent and Worker Agents) to automate clinical workflows, identity verification, and medical documentation in highly regulated transportation settings.
Engaging the Federal Aviation Administration (FAA) and the Department of Transportation (DOT) to support a 24-month Research, Development, Test & Evaluation (RDT&E) partnership aimed at reducing preventable in-flight medical diversions on commercial airlines. Advocating for future FAA rule making and operational standards regarding in-flight medical collaboration capabilities. Promoting the adoption of AI-powered governance platforms (specifically the Qortex AI Master Agent and Worker Agents) to automate clinical workflows, identity verification, and medical documentation in highly regulated transportation settings.
Engaging the Federal Aviation Administration (FAA) and the Department of Transportation (DOT) to support a 24-month Research, Development, Test & Evaluation (RDT&E) partnership aimed at reducing preventable in-flight medical diversions on commercial airlines. Advocating for future FAA rule making and operational standards regarding in-flight medical collaboration capabilities. Promoting the adoption of AI-powered governance platforms (specifically the Qortex AI Master Agent and Worker Agents) to automate clinical workflows, identity verification, and medical documentation in highly regulated transportation settings.
Engaging the Federal Aviation Administration (FAA) and the Department of Transportation (DOT) to support a 24-month Research, Development, Test & Evaluation (RDT&E) partnership aimed at reducing preventable in-flight medical diversions on commercial airlines. Advocating for future FAA rule making and operational standards regarding in-flight medical collaboration capabilities. Promoting the adoption of AI-powered governance platforms (specifically the Qortex AI Master Agent and Worker Agents) to automate clinical workflows, identity verification, and medical documentation in highly regulated transportation settings.
Engaging the Federal Aviation Administration (FAA) and the Department of Transportation (DOT) to support a 24-month Research, Development, Test & Evaluation (RDT&E) partnership aimed at reducing preventable in-flight medical diversions on commercial airlines. Advocating for future FAA rule making and operational standards regarding in-flight medical collaboration capabilities. Promoting the adoption of AI-powered governance platforms (specifically the Qortex AI Master Agent and Worker Agents) to automate clinical workflows, identity verification, and medical documentation in highly regulated transportation settings.